Fayrouz Maher Kamel Elshenawy

• Exploring the usability of wearable digital technology to monitor medication adherence and mobility in people with Parkinson’s Disease via a survey questionnaire
• MBBS (NUMed)

Parkinson’s disease (PD) is a chronic, progressive neurological disorder that impairs movement and often requires carefully timed medication schedules to maintain symptom control. Although drugs such as Levodopa can significantly improve mobility, their effectiveness varies throughout the day, leading to unpredictable symptom fluctuations that disrupt daily life.

Emerging digital health and wearable technologies (DHWT), including smartwatches and body-worn sensors, offer new opportunities to monitor mobility in real time. These tools provide meaningful data on how medication influences movement, supporting patients and clinicians in optimizing treatment decisions.

For these innovations to reach their full potential, they must reflect the real-world needs and preferences of people living with PD. This study explores medication adherence strategies, symptom fluctuation management, and the use of digital reminder technologies through an international survey of individuals with Parkinson’s disease. By centering patient perspectives, the research seeks to connect technology with personalized care—paving the way for more responsive and patient-focused PD management.